|
DENVER, April 24, 2019 /PRNewswire/ -- DaVita Kidney Care, a division of DaVita Inc. (NYSE: DVA), a leading provider of kidney... Read more ›› |
|
By: PR Newswire Association LLC. - 24 Apr 2019
|
|
Related companies:
DaVita Inc. |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 24 Apr 2019
|
|
Related companies:
MDXHEALTH, INC |
MDxHealth B.V. |
MDxHealth S.A. |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 24 Apr 2019
|
|
Related companies:
Novan, Inc. |
|
|
LOS ANGELES, April 23, 2019 /PRNewswire/ -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company focused on commercializing... Read more ›› |
|
By: PR Newswire Association LLC. - 24 Apr 2019
|
|
Related companies:
NeuroSigma, Inc. |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 24 Apr 2019
|
|
Related companies:
MediciNova, Inc. |
|
|
NEW YORK, April 23, 2019 /PRNewswire/ -- Read more ›› |
|
By: PR Newswire Association LLC. - 24 Apr 2019
|
|
|
NEW YORK, April 23, 2019 /PRNewswire/ -- Read more ›› |
|
By: PR Newswire Association LLC. - 24 Apr 2019
|
|
|
FLEMINGTON, N.J., April 23, 2019 /PRNewswire/ -- CGE is proud to announce a pilot partnership with Hunterdon Central Regional High School, designed... Read more ›› |
|
By: PR Newswire Association LLC. - 24 Apr 2019
|
|
|
NORTH CHICAGO, Ill., April 23, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved SKYRIZI(TM) (risankizumab-rzaa), an interleukin-23 (IL-23) inhibitor, for the treatment of moderate... Read more ›› |
|
By: PR Newswire Association LLC. - 24 Apr 2019
|
|
Related companies:
AbbVie Inc. |
|
|
NEW YORK, April 23, 2019 /PRNewswire/ -- Read more ›› |
|
By: PR Newswire Association LLC. - 24 Apr 2019
|
|
|
NEW YORK, April 23, 2019 /PRNewswire/ -- The report on the global medical sensor market provides qualitative and quantitative analysis for the period from 2017 to 2025.
Read the full report: Read more ›› |
|
By: PR Newswire Association LLC. - 24 Apr 2019
|
|
|
NEW YORK, April 23, 2019 /PRNewswire/ -- Read more ›› |
|
By: PR Newswire Association LLC. - 24 Apr 2019
|
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 23 Apr 2019
|
|
Related companies:
Merit Medical Systems, Inc. |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 23 Apr 2019
|
|
Related companies:
NeoChord, Inc. |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 23 Apr 2019
|
|
Related companies:
Myriad Genetics, Inc. |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 23 Apr 2019
|
|
Related companies:
Stryker Corporation |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 23 Apr 2019
|
|
Related companies:
Retrophin, Inc |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 23 Apr 2019
|
|
Related companies:
Harvard Bioscience, Inc. |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 23 Apr 2019
|
|
Related companies:
Psychemedics Corporation |
|
|
BELTON, Ky., April 23, 2019 /PRNewswire/ -- Bluegrass Farmaceuticals, a botanical therapeutics company, announced today... Read more ›› |
|
By: PR Newswire Association LLC. - 23 Apr 2019
|
|
|
|
|
|
Biotechgate Global Database ›
